• Co-founder and member of the board of directors of CervoMed, Inc.
  • Chair of the board of directors of Abivax SA.
  • Member of the board of directors of F2G Ltd.
  • Advisor to Sofinnova Telethon Fund.

  • President of Human Genetic Therapies Shire PLC, 2007-2013.
  • Executive chair of IDM Pharma Inc., 2006-2007.
  • President and chief executive officer in GlycoFi Inc., 2003-2004. 

  • Considered independent under the Danish Corporate Governance Recommendations.
  • Member of the Board of Directors since March 2015. Most recently elected in 2025 for a term of one year.
  • Member of the Audit Committee since March 2015. The Board has assessed that Ms Grégoire qualifies as independent pursuant to the US Securities Exchange Act.
  • Member of the Research & Development Committee since March 2017.
  • Member of the People and Governance Committee (previously the Nomination Committee) since March 2018.

  • Global corporate leadership.
  • Healthcare and pharma industry.
  • Medicine & science.
  • Finance & accounting.
  • Business development, M&A and external innovation sourcing.
  • Human capital management.

  • 1986: Pharmacy Doctorate degree, the State University of NY at Buffalo, US,
  • 1984: BA in Pharmacy, Laval University, Canada.
  • 1980: Science College degree, Séminaire de Sherbrooke, Canada.

Canadian and American, born 1961. Female.